Selected article for: "ace enzyme and acute sars"
Author: Turner, Anthony J; Hiscox, Julian A; Hooper, Nigel M
Title: ACE2: from vasopeptidase to SARS virus receptor
  • Cord-id: 4hxzdmkx
  • Document date: 2004_4_23
    • ID: 4hxzdmkx
    Snippet: The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus
    Document: The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1–7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.

    Search related documents:
    Co phrase search for related documents
    • ace active site and active site residue: 1
    • ace active site and acute respiratory syndrome: 1
    • ace angiotensin convert enzyme and acute respiratory syndrome: 1
    • ace convert and acute respiratory syndrome: 1
    • ace inhibitor and active site: 1, 2
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace prevalence and acute respiratory syndrome: 1, 2
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site model and acute respiratory syndrome: 1, 2
    • active site residue and acute respiratory syndrome: 1, 2